Evidence map›Paper›PMID 20535238›Full record

ArticleProteomics. Clinical applications2010

Candidate biomarkers in exosome-like vesicles purified from rat and mouse urine samples.

Javier Conde-Vancells, Eva Rodriguez-Suarez, Esperanza Gonzalez, Agustin Berisa, David Gil, Nieves Embade, Mikel Valle, Zigmund Luka, Felix Elortza, Conrad Wagner and 3 more

Open access · greenAbstract read
In one paragraph

Article in Proteomics. Clinical applications, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 71 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
71citing papers in PubMed, 2 pooled it
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

71 citing papers in PubMed, 2 syntheses or guidelines pooled it, 130 citations in OpenAlex.

  1. Pooled it
  2. Guideline
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Review
  18. Emerging roles for AQP in mammalian extracellular vesicles.Biochimica et biophysica acta. Biomembranes · 2022
    Review
  19. Article
  20. Review

11 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Javier Conde-VancellsMetabolomics Unit, CICbioGUNE, CIBERehd, Bizkaia Technology Park, Derio, Bizkaia, Spain.
Eva Rodriguez-Suarez
Esperanza Gonzalez
Agustin Berisa
David Gil
Nieves Embade
Mikel Valle
Zigmund Luka
Felix Elortza
Conrad Wagner
Shelly C Lu
Jose M Mato
M Falcon-Perez
CIC bioGUNE · ESVanderbilt University · USFaes Farma (Spain) · ESUniversity of Southern California · US

Funding

Role of SAMe in Pathogenesis and Treatment of Non-Alcholic Fatty Liver DiseaseR01AT001576 · NCCIH · UNIVERSITY OF SOUTHERN CALIFORNIA · PI LU, SHELLY CHI-LOO · 2002 to 2018
$5.0M
TISSUE STORES OF FOLATE: DIETARY CONTROL AND ASSAYR01DK015289 · NIDDK · VANDERBILT UNIVERSITY · PI WAGNER, CONRAD · 1987 to 2013
$3.1M
Folate and S-adenosyimethionine in Methyl Group and One-carbon MetabolismR01DK080010 · NIDDK · VANDERBILT UNIVERSITY · PI WAGNER, CONRAD · 2009 to 2012
$1.4M
TISSUE STORES OF FOLATE: DIETARY CONTROL AND ASSAYR37DK015289 · NIDDK · VANDERBILT UNIVERSITY · PI WAGNER, CONRAD · 1995 to 2002
$620k
NCCIH NIH HHS R01 AT001576NIDDK NIH HHS R01 DK015289NIDDK NIH HHS R01 DK080010NIDDK NIH HHS R37 DK015289
6 · The paper itself

Abstract

purposeThere is a compelling clinical imperative to identify discerning molecular biomarkers of hepatic disease in order to inform the diagnosis, prognosis and treatment. EXPERIMENTAL

designWe have investigated the proteome of urinary vesicles present in urine samples obtained from experimental models for the study of liver injury, as an approach for identifying potential biomarkers for hepatic disease.

resultsThe biochemical and proteomic characterization of highly purified exosome-like urinary vesicles has identified 28 proteins previously unreported in these vesicles, and many that have been previously associated with diseases, such as the prion-related protein. Furthermore, in urine samples from D-galactosamine-treated rats, a well-characterized experimental model for acute liver injury, we have detected a severe reduction in some proteins that normally are clearly detected in urinary vesicles. Finally, differential protein content on urinary vesicles from a mouse model for chronic liver injury has been also identified. CONCLUSIONS AND CLINICAL RELEVANCE: Our results argue positively that urinary vesicles could be a source for identifying non-invasive biomarkers of liver injury. We proposed some proteins such as Cd26, Cd81, Slc3A1 and Cd10 that have been found to be differentially expressed in urinary vesicles from some of the analyzed models as potential biomarkers for liver injury.

Indexed as

AnimalsBiomarkersBlotting, WesternDisease Models, AnimalExosomesGas Chromatography-Mass SpectrometryLiverMaleMiceRatsRats, WistarBiomarkersBiomarkerExosomesSubproteomeUrineVesicles

Identifiers

PMID20535238
PMCPMC2882112
OpenAlexW2045375216

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.